论文部分内容阅读
目的分析临床治疗支气管哮喘急性发作的方法。方法将36例支气管哮喘急性发作患者随机分为对照组和治疗组,对照组选用万托林气雾剂+氢化可的松琥珀酸钠+氨茶碱注射液治疗,治疗组选用舒利迭+孟鲁司特+氨茶碱注射液治疗。结果对照组总有效率为66.66%,治疗组总有效率为94.44%,差异有统计学意义(P<0.05)。结论支气管哮喘急性发作期除常规治疗外,使用舒利迭、孟鲁司特对改善患者临床症状、提高肺功能有积极作用,值得临床应用。
Objective To analyze the clinical treatment of acute exacerbation of bronchial asthma. Methods Thirty-six patients with acute exacerbation of bronchial asthma were randomly divided into the control group and the treatment group. The control group was treated with Wantroplin aerosol + hydrocortisone sodium succinate + aminophylline injection. The treatment group was treated with seretide + Montelukast + aminophylline injection. Results The total effective rate of the control group was 66.66%, the total effective rate of the treatment group was 94.44%, the difference was statistically significant (P <0.05). Conclusion In addition to the conventional treatment of acute exacerbation of bronchial asthma, the use of seretide, montelukast on patients with clinical symptoms and improve lung function has a positive effect, it is worth clinical application.